PARP Inhibition & Non-BRCA DNA Damage Repair Mutation Study Awarded $50,000 Grant

PARP inhibition and non-BRCA DNA damage repair mutation study by Dr Rinsinger has been awarded a $50,000 grant by the MIOCA Board of Directors.

They received several worthy proposals and it was a difficult decision, but are thrilled to be able to support Dr. Risinger's important work!